Quantcast

Posts related to ‘ONXX’

biotech

Top New Biotech Ideas from PropThink

Posted: May 16, 2013 at 7:30 am

The world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA) approval or a life-saving capital raise is the ...
Read Full Story »
pills

Deutsche Bank Firm on Biotech Stocks to Buy

Posted: May 15, 2013 at 8:10 am

Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the ...
Read Full Story »
biotech

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

Posted: February 8, 2013 at 10:10 am

Investing in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary ...
Read Full Story »
health care

Analyst Calls Cancer Treatments Major Biotech Focus in 2013 (AMGN, GSK, ALXN, ARIA, CELG, INCY, ONXX)

Posted: January 18, 2013 at 9:50 am

The dread and fear that can come with a cancer diagnosis have their roots in its killer nature. It is the number two cause of death in Americans, second only ...
Read Full Story »
NYSE-flag

Trader Alerts: 9 Big Stock Movers This Wednesday (BA, CMG, DELL, FIVE, GNW, ONXX, VRA, WEN, YHOO)

Posted: January 16, 2013 at 9:14 am

Many stocks are on the move this Wednesday morning and we are covering some of the key winners and losers for our readers. Boeing Co. (NYSE: BA) is trading lower ...
Read Full Story »
biotech

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Posted: January 9, 2013 at 7:27 am

Big biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the smaller players in the $1 billion to $5 billion range. ...
Read Full Story »
biotech

Nine Big Expected Biotech Winners for 2013 (ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Posted: December 20, 2012 at 6:21 am

24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in 2012. If you look at the consensus price targets from ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — December 19, 2012: Markets Open Mixed, Slide to a Close (C, SWHC, SD, ONXX, PNRA, ORCL, FDX, GIS, NAV, BBBY, JBL, PAYX, KMX, CCL, CAG, DFS, KBH, RAD, SCHL, GM, STP, CSIQ, LDK, THQI, ONTY)

Posted: December 19, 2012 at 4:03 pm

U.S. equity markets opened flat to higher this morning but the good vibe didn’t last long. In Europe, the Bank of England made no changes either to interest rates or ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades (BBT, CENT, C, GTAT, HBI, MDVN, ONXX, PNRA, RF, SD, SWHC, USB, WFC)

Posted: December 19, 2012 at 8:51 am

These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Wednesday. BB&T Corp. (NYSE: BBT) cut to Equal Weight at Morgan Stanley. ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades (ADTN, ATI, AIG, BYD, CLF, G, HON, INTC, IBM, KMP, ONXX, P, RAX, RSG, SN, TIBX, TUP, UTX, PAY, WM, WWAV)

Posted: December 5, 2012 at 8:45 am

These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Wednesday. ADTRAN Inc. (NASDAQ: ADTN) cut to Sell at Citigroup. Allegheny Technologies ...
Read Full Story »

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Posted: November 12, 2012 at 8:04 am

We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), ...
Read Full Story »

FDA Gives Nod to Onyx and Bayer for Stivarga in Gastrointestinal Tumors

Posted: October 29, 2012 at 11:58 am

There is some potentially very good news for those with gastrointestinal stromal tumors. The FDA has granted a priority review to the New Drug Application of Bayer HealthCare and Onyx ...
Read Full Story »

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Posted: October 25, 2012 at 7:41 am

We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), ...
Read Full Story »

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Posted: October 11, 2012 at 8:25 am

The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold ...
Read Full Story »

Top Analyst Upgrades and Downgrades (ALU, BLK, BBVA, CMCSA, DTV, DISH, TWC, HMC, KEY, LNKD, MXIM, ONXX, PNRA, PSX, RUSHA, TYC)

Posted: October 8, 2012 at 8:54 am

These are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Monday. Today's calls are light perhaps due to the Columbus Day holiday. ...
Read Full Story »